Further studies should aim to investigate if this potential renoprotective effect of PTH replacement therapy in hypoparathyroidism only applies to patients with an initial normal kidney function or also may be beneficial to patients with impaired kidney function. The gene discussed is PTH; the disease is hypoparathyroidism.